FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387357002: Benzocaine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461535019 Benzocaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481456011 Benzocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492018015 Ethyl aminobenzoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4499481000005118 Benzocain da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Benzocaine (substance) Is a Local anesthetic (substance) false Inferred relationship Some
Benzocaine (substance) Is a Drug allergen false Inferred relationship Some
Benzocaine (substance) Is a Aminobenzoic acid derivative false Inferred relationship Some
Benzocaine (substance) Is a lokalanæstetikum af estertype false Inferred relationship Some
Benzocaine (substance) Is a Ester false Inferred relationship Some
Benzocaine (substance) Is a anæstestikum til topial anvendelse false Inferred relationship Some
Benzocaine (substance) Is a Benzoic acid ester and/or benzoic acid ester derivative (substance) false Inferred relationship Some
Benzocaine (substance) Is a Benzoic acid ester local anesthetic true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Benzocaine 100 mg/g dental gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine poisoning Causative agent True Benzocaine (substance) Inferred relationship Some 1
Accidental benzocaine poisoning Causative agent False Benzocaine (substance) Inferred relationship Some
Intentional benzocaine poisoning Causative agent False Benzocaine (substance) Inferred relationship Some
forgiftning med benzocain, uvist med hvilken hensigt Causative agent False Benzocaine (substance) Inferred relationship Some 1
Benzocaine adverse reaction Causative agent True Benzocaine (substance) Inferred relationship Some 1
Allergy to benzocaine (finding) Causative agent False Benzocaine (substance) Inferred relationship Some
Benzocaine overdose (disorder) Causative agent True Benzocaine (substance) Inferred relationship Some 1
Accidental benzocaine overdose Causative agent True Benzocaine (substance) Inferred relationship Some 1
Intentional benzocaine overdose Causative agent True Benzocaine (substance) Inferred relationship Some 1
overdosis af benzocain, uvist med hvilken hensigt Causative agent False Benzocaine (substance) Inferred relationship Some 1
kombinationspræparat med benzocain 100 mg sugetablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain 1 mg halsspray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 30 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine compound injection solution BPC vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 20% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 200 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain 20 % salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain 20 % øredråber The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain 2% wt/wt + trimethobenzamidhydrochlorid 100 mg suppositorier The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing benzocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Antipyrine + benzocaine + glycerin 54mg/14mg/1cc solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
antipyrin + benzocain 5,4 % vægtvolumen/1,442 % vægtvolumen-opløsning The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain + trimethobenzamidhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
pyrilaminmaleat + benzocain The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
kombinationspræparat med benzocain 100 mg + menthol 3 mg sugetablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain + butamben + tetracainhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing benzocaine and phenazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine and menthol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine and resorcinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine and phenazone and phenylephrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and phenol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and triclosan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Accidental benzocaine poisoning Causative agent True Benzocaine (substance) Inferred relationship Some 1
Intentional benzocaine poisoning Causative agent True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine and mepyramine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and cetylpyridinium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and dequalinium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine and chloroxylenol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine and salicylamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and tyrothricin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Benzocaine-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine in oropharyngeal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing benzocaine in otic dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine in vaginal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Allergy to benzocaine (finding) Causative agent True Benzocaine (substance) Inferred relationship Some 1
Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Benzocaine (substance) Inferred relationship Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 1
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 1
Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 2
Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 2
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 1
Benzocaine 10 mg and dequalinium chloride 250 microgram oromucosal lozenge This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 1
Product containing benzocaine in dental dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine 30 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 1
Benzocaine 30 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine 100 mg/g dental gel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine 100 mg/g dental gel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 1
Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 1
Product containing precisely benzocaine 200 milligram/1 gram conventional release dental gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 2
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 2
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Benzocaine (substance) Inferred relationship Some 2
Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Benzocaine (substance) Inferred relationship Some 2
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Benzocaine (substance) Inferred relationship Some 2
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Benzocaine (substance) Inferred relationship Some 2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Benzocaine (substance) Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Benzocaine (substance) Inferred relationship Some 1
Benzocaine-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine- and cetylpyridinium-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and dequalinium in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine- and mepyramine-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Benzocaine- and tyrothricin-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing benzocaine and chloroxylenol in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine- and triclosan-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing only benzocaine and chloroxylenol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine and mepyramine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing only benzocaine and dequalinium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing only benzocaine and menthol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Benzocaine and phenol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing only benzocaine and cetylpyridinium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2
Product containing only benzocaine and phenazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing only benzocaine and resorcinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 1
Product containing only benzocaine and salicylamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Benzocaine (substance) Inferred relationship Some 2

Page 1 of 2 End


This concept is not in any reference sets

Back to Start